SAGE Therapeutics (SAGE), Biogen (BIIB) ZURZUVAETM approved in PPD, receives CRL for MDD
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 250.73 -3.11 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.84 | 52 Week High | $333.65 | |||
| Open | $251.68 | 52 Week Low | $223.02 | |||
| Day High | $252.27 | P/E | 32.10 | |||
| Day Low | $246.15 | EPS | $7.81 | |||
| Volume | 411,824 | |||||
| Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 8.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.68 | 52 Week High | $62.64 | |||
| Open | $8.68 | 52 Week Low | $26.28 | |||
| Day High | $8.68 | P/E | N/A | |||
| Day Low | $8.68 | EPS | $-0.94 | |||
| Volume | 53,187 | |||||
